Connecticut Bioscience Innovation Fund (CBIF)

Connecticut Bioscience Innovation Fund (CBIF) is a $200 million evergreen bioscience vehicle at Connecticut Innovations. The fund centers on bioscience and healthcare, with a company track that uses equity capital and a broader eligibility set that also includes academic, nonprofit, university, and research applicants. The route is rolling and designed for Connecticut-linked applicants in life sciences. The company side is for for-profit firms, and the broader eligibility set also includes academic, nonprofit, university, and research applicants. It is one of Connecticut Innovations' clearest bioscience channels and sits alongside the agency's other equity programs rather than outside them. The best fit is a Connecticut-linked bioscience company with a clear path to development, or an academic or nonprofit team with translational work that fits the broader bioscience mandate. The fund reads as a state-backed life-sciences channel that tries to move promising work from early formation into investable development, and that keeps it close to the state's wider bioscience base.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.